Tiotropium as Asthma Add-On Treatment Shows Promise Boehringer Ingelheim announced that the Food and Drug Administration (FDA) has approved Spiriva Respimat (tiotropium bromide) inhalation spray for ...

Want to know what asthma feels like? Try a crushing bear hug. That’s what patients told Boehringer Ingelheim, informing its latest campaign for Spiriva Respimat as a treatment for asthma. In new TV ...

Tiotropium (as bromide monohydrate) 1.25mcg, 2.5mcg; per actuation; inh spray; contains benzalkonium chloride. Spiriva Respimat Inhalation Spray is supplied in a carton containing one Spiriva Respimat ...

Spiriva (tiotropium bromide) is a prescription drug that’s used to treat COPD and asthma. The drug comes in an inhaler. It’s usually used once per day. Spiriva is a prescription drug that comes in two ...

Spiriva (tiotropium) is a prescription drug used to treat certain lung conditions. Spiriva can cause side effects that range from mild to serious. Examples include cough and dry mouth. Spiriva ...

The US Food and Drug Administration (FDA) yesterday approved an inhalation spray version of tiotropium bromide (Spiriva Respimat, Boehringer Ingelheim) for maintenance treatment of chronic obstructive ...

Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please ...

Boehringer Ingelheim is celebrating after the US Food and Drug Administration approved the mist version of its chronic obstructive pulmonary disease blockbuster Spiriva. Boehringer Ingelheim is ...

Boehringer Ingelheim is close to getting a licence for its chronic obstructive pulmonary disease blockbuster Spiriva as a treatment for asthma. Boehringer Ingelheim is close to getting a licence for ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Spiriva Respimat contains the active ingredient tiotropium. Spiriva ...

In laying out their respective plans Monday to launch new direct-to-patient (DTP) platforms paring down the prices of popular medicines in the U.S., Novartis and Boehringer Ingelheim are falling in ...

U.S. study finds 'excess number of deaths' after major study A mist inhaler used to improve breathing in people with lung diseases including chronic bronchitis and emphysema could increase the risk of ...